Quinolinone derivatives as tyrosine kinase inhibitors

Details for Australian Patent Application No. 2005202068 (hide)

Owner Chiron Corporation

Inventors Taylor, Clarke; McBride, Chris; Shafer, Cynthia; Pecchi, Sabina; McCrea, Bill; Machajewski, Tim; Jazan, Elisa; Renhowe, Paul

Agent FB Rice

Pub. Number AU-B-2005202068

Parent 2001293275

Filing date 13 May 2005

Wipo publication date 2 June 2005

Acceptance publication date 9 August 2007

International Classifications

C07D 401/04 (2006.01) Heterocyclic compounds containing two or more hetero rings

A61K 31/4704 (2006.01) - 2-Quinolinones, e.g. carbostyril

C07D 405/04 (2006.01) Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

C07D 409/04 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms

Event Publications

26 May 2005 Complete Application Filed

2 June 2005 Application Open to Public Inspection

  Published as AU-B-2005202068

9 August 2007 Application Accepted

  Published as AU-B-2005202068

6 December 2007 Standard Patent Sealed

20 November 2008 Alteration of Name

  The name of the patentee has been altered to Novartis Vaccines and Diagnostics, Inc.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005202069-Cornice fixing prop

2005202067-Foldable knife